Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Leukemia, Myeloid, Acute 45Breast Neoplasms 20Myelodysplastic Syndromes 19Prostatic Neoplasms 12Neoplasms 12Leukemia, Myelomonocytic, Chronic 12Carcinoma, Hepatocellular 10Stomach Neoplasms 9Recurrence 9Carcinoma, Non-Small-Cell Lung 8Neoplasm Metastasis 7Uterine Cervical Neoplasms 6Sarcoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Ovarian Neoplasms 6Multiple Myeloma 6Esophageal Neoplasms 6Myeloproliferative Disorders 5Melanoma 5Lymphoma, Non-Hodgkin 5Lymphoma, B-Cell 5Lung Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Biphenotypic, Acute 4Leukemia 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 4Cholangiocarcinoma 4

Interventions

Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Extrapulmonary Neuroendocrine Cancer × Injections × Clear all
NCT06951243 2025-04-30

A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer

Beijing GoBroad Hospital

Phase 2 Not yet recruiting
40 enrolled
Endocrine

Advanced Extrapulmonary Neuroendocrine Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡